No Data
No Data
No Data
No Data
No Data
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Yahoo Finance15:05
Earnings Call Summary | Amneal Pharmaceuticals(AMRX.US) Q1 2024 Earnings Conference
The following is a summary of the Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript:Financial Performance:Amneal Pharmaceuticals reported a Q1 2024 revenue of $659 million, an incre
Futu News10:55 · Conference Call
Amneal Stock Climbs on Q1 Report, Opioid Settlement Update
Seeking Alpha03:45
Amneal Pharmaceuticals: A Strong Buy on Robust Q1 Performance and Promising IPX-203 Launch
TipRanks02:15
Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating
Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating.
MT Newswires02:11
CORRECTION: Amneal Reaffirms 2024 Revenue Guidance Of $2.55B-$2.65B Versus Consensus Of $2.60B, With Adjusted EPS of $0.53-$0.63 Compared To Guidance Of $0.58
CORRECTION: Amneal Reaffirms 2024 Revenue Guidance Of $2.55B-$2.65B Versus Consensus Of $2.60B, With Adjusted EPS of $0.53-$0.63 Compared To Guidance Of $0.58
Benzinga02:09
No Data
No Data